Genmab: Q3 Looking Good, This Antibody Play Is STILL CHEAP
-
"In this no financial advice video, I present Genmab, a leader in antibody medicine and a provider of a novel approach for cancer treatment. I don't understand why Genmab (GMAB stock) is this cheap. No financial advice, but it looks to me like they had a greater Q3.
Let this video be simply a single datapoint in your own analysis of the stock and its potential. As always, this video is NOT investment advice, and none of the contents should be construed as such. I do not make short-term or long-term price predictions for any stock investment, and all words spoken in this video are for entertainment purposes ONLY . Also my Avatar was created with readyplayer.me, a great tool for creating metaverse-ready 3D avatars".
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind